CAG repeat expansions and schizophrenia: association with disease in females and with early age-at-onset

Human Molecular Genetics
A G MorrisD M Hunt

Abstract

An increase in the severity of schizophrenia through consecutive generations (anticipation) has been found in some studies of families with affected members. Anticipation in five neurological disorders is known to arise from the expansion of CAG repeats between generations of affected individuals. The 'repeat expansion detection' method was used to screen individual genomes for the size of such expansions in a sample of schizophrenic and normal subjects. Comparison of the frequency distribution of CAG expansions observed in schizophrenic patients to that for normal subjects, showed that there are significantly more expansions in patients (p = 0.048). When male and female subjects are considered separately, there is a highly significant difference in the distribution of repeat sizes found between affected and normal females (p = 0.0023) but no significant difference between affected and normal males. Overall there is a 28% excess of expansions observed in affected versus normal females, and their presence confers a relative risk of 4.12 (p < 0.005). In contrast, the frequency distribution of age-at-onset with respect to repeat size is nearly the same in male and female patients and, when the sexes are combined, the larger (CAG)6...Continue Reading

Citations

Apr 3, 2002·Journal of Biosciences·Suman PrasadB K Thelma
Sep 18, 1996·Schizophrenia Research·A S BassettW G Honer
Nov 5, 1997·Biological Psychiatry·K OharaZ C Wang
Mar 17, 2000·Brain Research. Brain Research Reviews·M J Owen
Mar 22, 2000·Psychiatry Research·T StompeA Friedmann
Jul 13, 2000·Psychiatry Research·K Ohara1S Tsuji
Mar 9, 2000·Psychiatry Research·K OharaK Ohara
Mar 27, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·K Ohara
Jan 1, 1997·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·P GorwoodJ Feingold
Feb 19, 1998·Schizophrenia Research·L E DeLisi
Feb 16, 1999·Schizophrenia Research·A HeidenH N Aschauer
Dec 14, 1999·Schizophrenia Research·M B Borrmann-HassenbachB Dreikorn
Nov 30, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·Agnes AytonDavid Cottrell
Mar 1, 1997·Molecular Medicine Today·G Kirov, R Murray
Dec 29, 1998·Molecular Medicine Today·J J GargusG A Gutman
Sep 25, 1997·Human Molecular Genetics·J E NielsenS A Sørensen
Oct 13, 2001·Schizophrenia Bulletin·D Malaspina
Oct 12, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·D G MurphyS I Rapoport
Aug 26, 1998·Acta Psychiatrica Scandinavica·D V JesteR K Heaton
Mar 1, 1996·Acta Paediatrica·K Lindblad, M Schalling
Jun 22, 1999·Biological Psychiatry·A G CardnoM C O'Donovan
Nov 24, 1999·DNA Sequence : the Journal of DNA Sequencing and Mapping·C ZühlkeE Schwinger
Oct 19, 2010·Frontiers in Neuroendocrinology·Tuck C NgunEric Vilain
Oct 11, 2002·Mayo Clinic Proceedings·Janet L SobellCynthia T McMurray
Apr 10, 2003·The Psychiatric Clinics of North America·Colm McDonald, Kieran C Murphy
Aug 12, 1999·American Journal of Human Genetics·M C O'Donovan, M J Owen
Dec 9, 1997·Neuron·M Karayiorgou, J A Gogos
Mar 1, 1996·Current Biology : CB·E Dawson, R Murray
Feb 15, 2001·American Journal of Human Genetics·M Baron
Jun 19, 1998·American Journal of Human Genetics·E SidranskyE I Ginns
Dec 3, 1999·American Journal of Medical Genetics·M G McInnisL E DeLisi
May 17, 2000·American Journal of Medical Genetics·J B VincentJ L Kennedy
Feb 21, 1997·American Journal of Medical Genetics·M C O'Donovan, C Guy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.